Aug 23 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO
* Paul Herendeen to receive base salary of $1 million, a target annual bonus opportunity equal to 120 percent of base salary
* On first regular payroll date, Herendeen to get cash payment equal to $10 million - SEC filing
* In connection with entering into employment agreement, Herendeen received 1 million stock options, 150,000 restricted stock units Source: Further company coverage: VRX.TO